Literature DB >> 14141840

DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS.

E M CAFFEY, L S DIAMOND, T V FRANK, J C GRASBERGER, L HERMAN, C J KLETT, C ROTHSTEIN.   

Abstract

Entities:  

Keywords:  BEHAVIOR; CHLORPROMAZINE; CLINICAL RESEARCH; DRUG WITHDRAWAL SYMPTOMS; PLACEBOS; PSYCHOLOGICAL TESTS; SCHIZOPHRENIA; THIORIDAZINE

Mesh：

Substances：

Year:  1964        PMID： 14141840     DOI： 10.1016/0021-9681(64)90075-x

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN： 0021-9681


× No keyword cloud information.
  6 in total

1.  CHANGES IN SCHIZOPHRENIA.

Authors:  J C GRIFFITHS; W F TOOMEY
Journal:  Br Med J       Date:  1965-01-16

Review 2.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

Review 3.  Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.

Authors:  L E Hollister
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 4.  Psychotropic drugs.

Authors:  J Hinton
Journal:  Postgrad Med J       Date:  1968-04       Impact factor: 2.401

Review 5.  Intramuscular preparations of antipsychotics: uses and relevance in clinical practice.

Authors:  A Cario Altamura; Francesca Sassella; Annalisa Santini; Clauno Montresor; Sara Fumagalli; Emanuela Mundo
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Depot antipsychotic drugs. Place in therapy.

Authors:  J M Davis; L Matalon; M D Watanabe; L Blake; L ] Metalon L [corrected to Matalon
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.